-
1
-
2by Gabrielle Rees, Manuel Salto‐Tellez, Jessica L Lee, Karin Oien, Clare Verrill, Alex Freeman, Ilaria Mirabile, Nicholas P West, on behalf of the National Cancer Research Institute (NCRI) Cellular‐Molecular Pathology (CM‐Path) clinical trials working groupGet full text
Published 2019-04-01
Article